994 results on '"Feaster, Daniel J."'
Search Results
2. Psychosocial Factors Linked to Uncontrolled Infection and Mortality among People Living with HIV Who Use Substances: A Latent Class Analysis
3. Functions of Resiliency Traits and Processes in Differential Effects of CBSM on Quality of Life in Breast Cancer Survivors: A Moderated Mediation Model
4. Disadvantaged groups have greater spatial access to pharmacies in New York state
5. Project CHARIOT: study protocol for a hybrid type 1 effectiveness-implementation study of comprehensive tele-harm reduction for engagement of people who inject drugs in HIV prevention services
6. Bon Sante (Good Health): Factors Influencing PrEP Use Among Haitians/Haitian Americans
7. Strategies of Managing Repeated Measures: Using Synthetic Random Forest to Predict HIV Viral Suppression Status Among Hospitalized Persons with HIV
8. PrEP for people who use opioids: A NIDA clinical trials network survey study in Southern U.S. cities where HIV incidence is high
9. A study protocol for Project I-Test: a cluster randomized controlled trial of a practice coaching intervention to increase HIV testing in substance use treatment programs
10. Project T-SHARP: study protocol for a multi-site randomized controlled trial of tele-harm reduction for people with HIV who inject drugs
11. Human Immunodeficiency Virus transmission by HIV Risk Group and Along the HIV Care Continuum: A Contrast of 6 US Cities.
12. Improving health equity and ending the HIV epidemic in the USA: a distributional cost-effectiveness analysis in six cities
13. The Potential Epidemiological Impact of Coronavirus Disease 2019 (COVID-19) on the Human Immunodeficiency Virus (HIV) Epidemic and the Cost-effectiveness of Linked, Opt-out HIV Testing: A Modeling Study in 6 US Cities
14. Estimating the epidemiological impact of reaching the objectives of the Florida integrated HIV prevention and care plan in Miami-Dade County
15. Risks of returning to opioid use at treatment entry and early in opioid use disorder treatment: Role of non-opioid substances
16. Geo-spatial risk factor analysis for drug overdose death in South Florida from 2014 to 2019, and the independent contribution of social determinants of health
17. “Ending the Epidemic” Will Not Happen Without Addressing Racial/Ethnic Disparities in the United States Human Immunodeficiency Virus Epidemic
18. Hazardous alcohol use, antiretroviral therapy receipt, and viral suppression in people living with HIV who inject drugs in the United States, India, Russia, and Vietnam.
19. Can the 'Ending the HIV Epidemic' initiative transition the USA towards HIV/AIDS epidemic control?
20. Ending the HIV Epidemic Among Persons Who Inject Drugs: A Cost-Effectiveness Analysis in Six US Cities
21. Ending the HIV epidemic in the USA: an economic modelling study in six cities
22. The impact of localized implementation: determining the cost-effectiveness of HIV prevention and care interventions across six United States cities.
23. Development and Calibration of a Dynamic HIV Transmission Model for 6 US Cities
24. Randomized controlled trial of a positive affect intervention to reduce HIV viral load among sexual minority men who use methamphetamine
25. Ending the Epidemic in America Will Not Happen if the Status Quo Continues: Modeled Projections for Human Immunodeficiency Virus Incidence in 6 US Cities.
26. Soluble Plasma Proteins of Tumor Necrosis Factor and Immunoglobulin Superfamilies Reveal New Insights into Immune Regulation in People with HIV and Opioid Use Disorder
27. Recruitment into a Clinical Trial of People Living with Uncontrolled HIV Infection Who Inject Drugs: a Site Case Report from the CTN 67 CHOICES Study
28. What is the prevalence of and trend in opioid use disorder in the United States from 2010 to 2019? Using multiplier approaches to estimate prevalence for an unknown population size
29. Efficacy of a Family-Based Intervention for HIV Prevention with Hispanic Adolescents with Same Gender Sexual Behaviors
30. Performance of model-based vs. permutation tests in the HEALing (Helping to End Addiction Long-termSM) Communities Study, a covariate-constrained cluster randomized trial
31. Correction: M2HepPrEP: study protocol for a multi-site multi-setting randomized controlled trial of integrated HIV prevention and HCV care for PWID
32. M2HepPrEP: study protocol for a multi-site multi-setting randomized controlled trial of integrated HIV prevention and HCV care for PWID
33. Impact of COVID-19 on HIV service delivery in Miami-Dade County: a mixed methods study
34. Cost of Hepatitis C care facilitation for HIV/Hepatitis C Co-infected people who use drugs
35. Estimating Individual Treatment Effect in Observational Data Using Random Forest Methods
36. Estimating the potential value of MSM‐focused evidence‐based implementation interventions in three Ending the HIV Epidemic jurisdictions in the United States: a model‐based analysis.
37. Association of negative financial shocks during the Great Recession with depressive symptoms and substance use in the USA : the CARDIA study
38. Daily Microaggressions and Related Distress among Black Women Living with HIV during the Onset of the COVID-19 Pandemic and Black Lives Matter Protests
39. The association of periodontal disease and cardiovascular disease risk: Results from the Hispanic Community Health Study/Study of Latinos
40. Acceptability, feasibility, and pilot results of the tele-harm reduction intervention for rapid initiation of antiretrovirals among people who inject drugs
41. Simulating the Simultaneous Impact of Medication for Opioid Use Disorder and Naloxone on Opioid Overdose Death in Eight New York Counties
42. The impact of the national stay-at-home order on emergency department visits for suspected opioid overdose during the first wave of the COVID-19 pandemic
43. Improving health equity and ending the HIV epidemic in the USA: a distributional cost-effectiveness analysis in six cities
44. Reduction in injection risk behaviors after implementation of a syringe services program, Miami, Florida
45. An autoregressive cross-lagged model unraveling co-occurring stimulant use and HIV: Results from a randomized controlled trial
46. Understanding Willingness to Participate in HIV Biomedical Research: A Mixed Methods Investigation
47. LGB-Affirming School Climates and Sexual Health Outcomes Among U.S. High School Students 2015–2017: Differences by Sex and Sexual Identity
48. Self-efficacy as a mediator of patient navigation interventions to engage persons living with HIV and substance use
49. Trauma exposure, PTSD, and suboptimal HIV medication adherence among marginalized individuals connected to public HIV care in Miami
50. Dental Care Utilization of Hospitalized Persons Living with HIV and Substance Use
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.